AMSF 📈 AMERISAFE - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US03071H1005
AMSF: Workers' Compensation, Insurance, Benefits
AMERISAFE, Inc., an insurance holding company, underwrites workers' compensation insurance in the United States. The company provides benefits to injured employees for temporary or permanent disability, death, and medical and hospital expenses. It sells its products through retail and wholesale brokers and agents; and small and mid-sized employers engaged in hazardous industries, including construction, trucking, logging and lumber, agriculture, manufacturing, telecommunications, and maritime. AMERISAFE, Inc. was incorporated in 1985 and is based in DeRidder, Louisiana. Web URL: https://www.amerisafe.com
Additional Sources for AMSF Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
AMSF Stock Overview
| Market Cap in USD | 1,017m |
| Sector | Financial Services |
| Industry | Insurance - Specialty |
| GiC Sub-Industry | Property & Casualty Insurance |
| IPO / Inception | 2005-11-18 |
AMSF Stock Ratings
| Growth 5y | 2.88% |
| Fundamental | 8.78% |
| Dividend | 58.8% |
| Rel. Strength Industry | -50.8 |
| Analysts | 3.33/5 |
| Fair Price Momentum | 52.61 USD |
| Fair Price DCF | 22.38 USD |
AMSF Dividends
| Dividend Yield 12m | 8.54% |
| Yield on Cost 5y | 8.73% |
| Annual Growth 5y | -21.28% |
| Payout Consistency | 85.3% |
AMSF Growth Ratios
| Growth Correlation 3m | 63.4% |
| Growth Correlation 12m | 46.4% |
| Growth Correlation 5y | -16.6% |
| CAGR 5y | 0.44% |
| CAGR/Mean DD 5y | 0.02 |
| Sharpe Ratio 12m | 0.48 |
| Alpha | -2.61 |
| Beta | 0.57 |
| Volatility | 24.11% |
| Current Volume | 386.1k |
| Average Volume 20d | 155k |
What is the price of AMSF stocks?
As of December 22, 2024, the stock is trading at USD 52.47 with a total of 386,058 shares traded.
Over the past week, the price has changed by -2.29%, over one month by -8.71%, over three months by +10.21% and over the past year by +16.23%.
As of December 22, 2024, the stock is trading at USD 52.47 with a total of 386,058 shares traded.
Over the past week, the price has changed by -2.29%, over one month by -8.71%, over three months by +10.21% and over the past year by +16.23%.
Is AMERISAFE a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, AMERISAFE is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 8.78 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AMSF as of December 2024 is 52.61. This means that AMSF is currently overvalued and has a potential downside of 0.27%.
Neither. Based on ValueRay Fundamental Analyses, AMERISAFE is currently (December 2024) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of 8.78 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AMSF as of December 2024 is 52.61. This means that AMSF is currently overvalued and has a potential downside of 0.27%.
Is AMSF a buy, sell or hold?
AMERISAFE has received a consensus analysts rating of 3.33. Therefor, it is recommend to hold AMSF.
AMERISAFE has received a consensus analysts rating of 3.33. Therefor, it is recommend to hold AMSF.
- Strong Buy: 0
- Buy: 1
- Hold: 2
- Sell: 0
- Strong Sell: 0
What are the forecast for AMSF stock price target?
According to ValueRays Forecast Model, AMSF AMERISAFE will be worth about 57.7 in December 2025. The stock is currently trading at 52.47. This means that the stock has a potential upside of +9.99%.
According to ValueRays Forecast Model, AMSF AMERISAFE will be worth about 57.7 in December 2025. The stock is currently trading at 52.47. This means that the stock has a potential upside of +9.99%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 56.3 | 7.4% |
| Analysts Target Price | 56.7 | 8% |
| ValueRay Target Price | 57.7 | 10% |